U.S. markets closed

AngioDynamics, Inc. (ANGO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.23-0.09 (-0.36%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close25.32
Open25.35
Bid25.20 x 800
Ask25.21 x 800
Day's Range25.01 - 25.49
52 Week Range8.05 - 25.75
Volume122,121
Avg. Volume241,267
Market Cap962.207M
Beta (5Y Monthly)0.82
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System
    Business Wire

    AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System

    AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the AlphaVac Mechanical Thrombectomy System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the non-surgical removal of thrombi or emboli from the vasculature.

  • AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors
    GlobeNewswire

    AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

    VALENCIA, Calif. and MELBOURNE, Australia, June 01, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today the appointment of James Corbett and Jan Stern Reed to its Board of Directors effective July 1, 2021. Mr. Corbett has approximately 40 years of leadership experience in

  • AngioDynamics to Present at the UBS Virtual Global Healthcare Conference
    Business Wire

    AngioDynamics to Present at the UBS Virtual Global Healthcare Conference

    AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, will present at the UBS Virtual Global Healthcare Conference at 12:00 p.m. ET on Tuesday, May 25, 2021.